Private Equity
Location
Rotterdam, The Netherlands
Boston, MA, USA
Private Equity
All Portfolio items
See full Private Equity portfolio
Viroclinics Biosciences is a leader in diagnostic and clinical-trial services. It is one of the few labs in the world able to perform highly complex, specialized diagnostic and preclinical studies in the field of virology. Viroclinics operates globally as the preferred virology testing laboratory for top-ten biopharmaceutical companies.
Gilde acquired a majority share in 2013. During Gilde ownership Viroclinics developed new services for the biopharmaceutical industry, expanded its facilities and tripled its revenues. Viroclinics was sold in 2017 to Parcom Capital.
More Viroclinics Biosciences news
d3 Medicine LLC and Viroclinics Biosciences BV form virology drug development alliance to serve the
Gilde Healthcare Services acquires majority share in Viroclinics Biosciences from Erasmus MC
Private Equity
Klifo
KLIFO is a leading drug development consultancy headquartered in Copenhagen with extensive experience in partnering with biotech and pharmaceutical companies to advance their drug development projects. The company is a leader in the Scandinavian market and has operations in Germany
Private Equity
NIZO
NIZO is a state-of-the art, globally operating contract research organization for better food and health outcomes with headquarters in Ede, the Netherlands. It focuses on the development and application of innovative technologies for its customers in the global food industry
Private Equity
Chr. Diener / Koscher & Würtz
Chr. Diener and Koscher & Würtz form a leading group of specialized contract manufacturers, focused on designing and producing precision reuseable and disposable surgical instruments. The group employs approximately 300 highly skilled workers across three production locations in the Tuttlingen
